Amazon.com Inc vs Humana Inc — how do they compare? Amazon.com Inc trades at $244.73 (market cap $2.64T), while Humana Inc trades at $396.45 (market cap $47.09B). The key difference: Amazon.com Inc is far larger — about 56.1× Humana Inc's market cap, and Humana Inc pays a 0.9% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| AMZN | HUM | |
|---|---|---|
Market Cap | $2.64T | $47.09B |
Volume | 3,931,282 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $274.95 | $409.42 |
52-Week Low | $198.79 | $163.67 |
Enterprise Value | $2.71T | $56.13B |
Dividend Yield | — | 0.9% |
Signals from Pluang's Aura AI — not financial advice
Amazon (AMZN) trades at $245.34, down 0.69% over the past day, with a bullish technical outlook supported by moving averages and strong support at $241. The company reported robust fundamentals with 2025 revenue of $716.92B and net income of $77.67B, reflecting a 10.83% margin. Recent Q1 2026 earnings beat expectations with EPS of $2.78 vs. $1.63 expected. Operating cash flow reached $139.51B in 2025, though heavy investing outflows continue for growth initiatives.
Outlook remains positive with 88.3% analyst buy ratings and a $320.75 consensus price target, implying significant upside. Key risks include intense competition in retail and cloud, high valuation multiples, and macroeconomic sensitivity. Growth drivers include AWS expansion and AI investments, but execution on capex and margin sustainability are critical for continued shareholder value.
Humana (HUM) trades at $392.22, down 1.39% on the day, with technical indicators showing a bullish trend despite near-term overbought signals. The company reported revenue growth to $129.66 billion in 2025 but faces margin compression, with net income margin declining to 0.82%. Recent news highlights strategic shifts, including the $900 million divestiture of its Gentiva stake and expansion of Medicaid contracts, while legal investigations into fiduciary duties and healthcare cost disclosures present headwinds.
The stock's outlook is mixed: bullish technicals and revenue growth contrast with margin pressures and legal risks. Analysts are cautious, with a consensus price target of $327.07 below the current price, suggesting limited upside. Investment opportunities lie in Humana's strategic focus on profitability and CenterWell growth, but risks include regulatory scrutiny and execution challenges in a competitive healthcare landscape.
Trailing returns across standard periods
Latest headlines on both assets
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →